Published in J Palliat Med on March 06, 2015
Opportunities to maximize value with integrated palliative care. J Multidiscip Healthc (2016) 0.75
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Prevalence of kidney stones in the United States. Eur Urol (2012) 9.42
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol (2002) 4.13
Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol (2003) 4.11
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. J Natl Cancer Inst (2010) 3.24
Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14
Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst (2002) 3.00
Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones. JAMA Surg (2014) 2.89
Urologic diseases in America Project: analytical methods and principal findings. J Urol (2005) 2.87
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74
Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst (2004) 2.66
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Spirituality influences health related quality of life in men with prostate cancer. Psychooncology (2006) 2.65
Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer (2010) 2.61
Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol (2003) 2.44
Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41
Diffusion of surgical innovation among patients with kidney cancer. Cancer (2008) 2.38
Prostate cancer severity among low income, uninsured men. J Urol (2008) 2.38
Trends in stricture management among male Medicare beneficiaries: underuse of urethroplasty? Urology (2010) 2.37
Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst (2009) 2.28
Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population. Urology (2011) 2.26
Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst (2010) 2.17
Comorbidity and competing risks for mortality in men with prostate cancer. Cancer (2011) 2.17
Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology (2009) 2.16
Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer (2007) 2.13
Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer (2014) 2.07
Quality of diagnostic staging in patients with bladder cancer: a process-outcomes link. Cancer (2014) 2.06
Compliance with antibiotic prophylaxis in children with vesicoureteral reflux: results from a national pharmacy claims database. J Urol (2010) 2.05
Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol (2011) 2.05
The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol (2006) 2.02
Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol (2011) 1.97
Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer (2009) 1.95
Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer (2008) 1.89
Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87
Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst (2013) 1.86
Correlates of bother following treatment for clinically localized prostate cancer. J Urol (2010) 1.82
Variation in continence and potency by definition. J Urol (2003) 1.75
Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73
Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol (2009) 1.72
A systematic review of satisfaction with care at the end of life. J Am Geriatr Soc (2007) 1.71
Quality of surveillance for stage I testis cancer in the community. J Clin Oncol (2009) 1.69
Variations in reconstruction after radical cystectomy. Cancer (2006) 1.69
Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med (2011) 1.69
Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer (2004) 1.64
Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer (2010) 1.63
Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med (2009) 1.62
The demographic burden of urologic diseases in America. Urol Clin North Am (2009) 1.61
Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol (2011) 1.59
Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer. Arch Intern Med (2010) 1.59
Emergency department revisits for patients with kidney stones in California. Acad Emerg Med (2015) 1.56
Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol (2007) 1.56
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer (2014) 1.55
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55
Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55
Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol (2004) 1.52
Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer. Cancer (2013) 1.51
Health related quality of life in men with prostate cancer. J Urol (2003) 1.51
Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. J Clin Oncol (2005) 1.50
Trends in the surgical management of stress urinary incontinence among female Medicare beneficiaries, 2002-2007. Urology (2013) 1.49
Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49
Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort. Urology (2011) 1.48
Downstream complications following urinary diversion. J Urol (2013) 1.48
The effect of concomitant prolapse repair on sling outcomes. J Urol (2008) 1.47